应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KNSA Kiniksa Pharmaceuticals Ltd.
休市中 05-17 16:00:00 EDT
19.77
-0.34
-1.69%
盘后
19.77
+0.00
0.00%
16:20 EDT
最高
20.18
最低
19.72
成交量
25.77万
今开
20.18
昨收
20.11
日振幅
2.29%
总市值
14.02亿
流通市值
4.23亿
总股本
7,094万
成交额
511.35万
换手率
1.20%
流通股本
2,142万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Kiniksa Pharmaceuticals(KNSA.US)获富国银行首次覆盖,给予增持评级, 目标价34.00美元。
智通财经 · 05-04
Kiniksa Pharmaceuticals(KNSA.US)获富国银行首次覆盖,给予增持评级, 目标价34.00美元。
Kiniksa Pharmaceuticals, Ltd.盘中异动 大幅拉升5.21%
自选股智能写手 · 05-03
Kiniksa Pharmaceuticals, Ltd.盘中异动 大幅拉升5.21%
Kiniksa Pharmaceuticals, Ltd.盘中异动 股价大涨5.24%
自选股智能写手 · 05-02
Kiniksa Pharmaceuticals, Ltd.盘中异动 股价大涨5.24%
小摩:维持Kiniksa Pharmaceuticals(KNSA.US)评级,由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。
智通财经 · 05-01
小摩:维持Kiniksa Pharmaceuticals(KNSA.US)评级,由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。
Kiniksa Pharmaceuticals, Ltd.2024财年第一财季实现净利润-17.70百万美元,同比减少44.25%
自选股智能写手 · 04-27
Kiniksa Pharmaceuticals, Ltd.2024财年第一财季实现净利润-17.70百万美元,同比减少44.25%
Kiniksa Pharmaceuticals, Ltd.盘中异动 快速上涨5.06%
自选股智能写手 · 04-24
Kiniksa Pharmaceuticals, Ltd.盘中异动 快速上涨5.06%
Kiniksa Pharmaceuticals, Ltd.盘中异动 早盘股价大跌5.08%
自选股智能写手 · 04-02
Kiniksa Pharmaceuticals, Ltd.盘中异动 早盘股价大跌5.08%
Kiniksa Pharmaceuticals, Ltd.盘中异动 早盘股价大跌5.11%
自选股智能写手 · 03-04
Kiniksa Pharmaceuticals, Ltd.盘中异动 早盘股价大跌5.11%
Kiniksa Pharmaceuticals, Ltd.2023财年实现净利润14.08百万美元,同比减少92.31%
自选股智能写手 · 03-04
Kiniksa Pharmaceuticals, Ltd.2023财年实现净利润14.08百万美元,同比减少92.31%
Kiniksa Pharmaceuticals, Ltd.盘中异动 股价大涨5.21%
自选股智能写手 · 03-01
Kiniksa Pharmaceuticals, Ltd.盘中异动 股价大涨5.21%
Kiniksa Pharmaceuticals Ltd盘中异动 早盘股价大跌5.52%报19.74美元
自选股智能写手 · 02-28
Kiniksa Pharmaceuticals Ltd盘中异动 早盘股价大跌5.52%报19.74美元
Kiniksa Pharmaceuticals Ltd盘中异动 大幅拉升5.10%
自选股智能写手 · 02-10
Kiniksa Pharmaceuticals Ltd盘中异动 大幅拉升5.10%
Kiniksa Pharmaceuticals Ltd盘中异动 股价大涨5.02%报19.03美元
自选股智能写手 · 02-09
Kiniksa Pharmaceuticals Ltd盘中异动 股价大涨5.02%报19.03美元
Kiniksa Pharmaceuticals Ltd盘中异动 大幅上涨5.12%
自选股智能写手 · 01-12
Kiniksa Pharmaceuticals Ltd盘中异动 大幅上涨5.12%
Kiniksa Pharmaceuticals Ltd盘中异动 股价大跌5.05%报18.16美元
自选股智能写手 · 01-06
Kiniksa Pharmaceuticals Ltd盘中异动 股价大跌5.05%报18.16美元
Kiniksa Pharmaceuticals Ltd盘中异动 早盘快速跳水5.81%
自选股智能写手 · 01-04
Kiniksa Pharmaceuticals Ltd盘中异动 早盘快速跳水5.81%
Kiniksa Pharmaceuticals Ltd盘中异动 早盘股价大涨5.05%
自选股智能写手 · 01-03
Kiniksa Pharmaceuticals Ltd盘中异动 早盘股价大涨5.05%
Kiniksa Pharmaceuticals Ltd盘中异动 股价大涨5.99%
自选股智能写手 · 01-02
Kiniksa Pharmaceuticals Ltd盘中异动 股价大涨5.99%
Kiniksa Pharmaceuticals Ltd盘中异动 下午盘快速下挫5.03%报18.11美元
自选股智能写手 · 2023-12-21
Kiniksa Pharmaceuticals Ltd盘中异动 下午盘快速下挫5.03%报18.11美元
Kiniksa Pharmaceuticals Ltd盘中异动 快速上涨5.56%
自选股智能写手 · 2023-12-19
Kiniksa Pharmaceuticals Ltd盘中异动 快速上涨5.56%
暂无数据
公司概况
公司名称:
Kiniksa Pharmaceuticals Ltd.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Kiniksa Pharmaceuticals, Ltd.于2015年7月21日在百慕大成立.该公司是一家生物制药公司,专注于发现、获取、开发和商业化治疗药物,为患有严重未满足医疗需求的使人衰弱的疾病的患者提供治疗药物。该公司的免疫调节组合ARCALYST、KPL-404和mavrilimumab基于强大的生物学原理或经过验证的机制,针对一系列未得到充分治疗的心血管和自身免疫疾病,并提供差异化的潜力。
发行价格:
--
{"stockData":{"symbol":"KNSA","market":"US","secType":"STK","nameCN":"Kiniksa Pharmaceuticals Ltd.","latestPrice":19.77,"timestamp":1715976000000,"preClose":20.11,"halted":0,"volume":257669,"hourTrading":{"tag":"盘后","latestPrice":19.77,"preClose":19.77,"latestTime":"16:20 EDT","volume":15577,"amount":307957.29,"timestamp":1715977200484},"delay":0,"floatShares":21415864,"shares":70940145,"eps":0.12308,"marketStatus":"休市中","marketStatusCode":7,"change":-0.34,"latestTime":"05-17 16:00:00 EDT","open":20.18,"high":20.18,"low":19.72,"amount":5113520.667052,"amplitude":0.022874,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.12308,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1527134400000,"adjPreClose":20.11,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":19.77,"preClose":19.77,"latestTime":"16:20 EDT","volume":15577,"amount":307957.29,"timestamp":1715977200484},"volumeRatio":0.997927995614425},"requestUrl":"/m/hq/s/KNSA/tweets","defaultTab":"tweets","newsList":[{"id":"2432518834","title":"Kiniksa Pharmaceuticals(KNSA.US)获富国银行首次覆盖,给予增持评级, 目标价34.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432518834","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432518834?lang=zh_cn&edition=full","pubTime":"2024-05-04 00:05","pubTimestamp":1714752314,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals(KNSA.US)获富国银行首次覆盖,给予增持评级, 目标价34.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040005198b70c8c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405040005198b70c8c1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432908679","title":"Kiniksa Pharmaceuticals, Ltd.盘中异动 大幅拉升5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432908679","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432908679?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:32","pubTimestamp":1714743124,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时32分,Kiniksa Pharmaceuticals, Ltd.股票出现异动,股价大幅上涨5.21%。Kiniksa Pharmaceuticals, Ltd.股票所在的生物技术行业中,整体跌幅为0.15%。Kiniksa Pharmaceuticals, Ltd.公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。该信息摘要如下:小摩:维持Kiniksa Pharmaceuticals评级,由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213205861ead38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240503213205861ead38&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432261638","title":"Kiniksa Pharmaceuticals, Ltd.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432261638","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432261638?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:42","pubTimestamp":1714588936,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时42分,Kiniksa Pharmaceuticals, Ltd.股票出现波动,股价大幅上涨5.24%。Kiniksa Pharmaceuticals, Ltd.股票所在的生物技术行业中,整体涨幅为1.75%。Kiniksa Pharmaceuticals, Ltd.公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。该信息摘要如下:小摩:维持Kiniksa Pharmaceuticals评级,由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502024216861ea927&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502024216861ea927&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432501614","title":"小摩:维持Kiniksa Pharmaceuticals(KNSA.US)评级,由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432501614","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432501614?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:55","pubTimestamp":1714575342,"startTime":"0","endTime":"0","summary":"小摩:维持Kiniksa Pharmaceuticals(KNSA.US)评级,由增持调整至增持评级, 目标价由26.00美元调整至30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012255468b6a27f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012255468b6a27f0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430371437","title":"Kiniksa Pharmaceuticals, Ltd.2024财年第一财季实现净利润-17.70百万美元,同比减少44.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430371437","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430371437?lang=zh_cn&edition=full","pubTime":"2024-04-27 06:09","pubTimestamp":1714169379,"startTime":"0","endTime":"0","summary":"3月31日,Kiniksa Pharmaceuticals, Ltd.公布财报,公告显示公司2024财年第一财季净利润为-17.70百万美元,同比减少44.25%;其中营业收入为79.86百万美元,同比增加65.17%,每股基本收益为-0.25美元。机构评级:截至2024年3月31日,当前有5家机构对Kiniksa Pharmaceuticals, Ltd.目标价做出预测,其中目标均价为29.20美元,其中最低目标价为26.00美元,最高目标价为32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270609488b589edf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270609488b589edf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429112842","title":"Kiniksa Pharmaceuticals, Ltd.盘中异动 快速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429112842","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429112842?lang=zh_cn&edition=full","pubTime":"2024-04-24 00:03","pubTimestamp":1713888181,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日00时03分,Kiniksa Pharmaceuticals, Ltd.股票出现波动,股价快速上涨5.06%。Kiniksa Pharmaceuticals, Ltd.股票所在的生物技术行业中,整体涨幅为1.38%。Kiniksa Pharmaceuticals, Ltd.公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240003017a54f36b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240003017a54f36b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424495220","title":"Kiniksa Pharmaceuticals, Ltd.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424495220","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424495220?lang=zh_cn&edition=full","pubTime":"2024-04-02 22:03","pubTimestamp":1712066637,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日22时03分,Kiniksa Pharmaceuticals, Ltd.股票出现异动,股价急速下挫5.08%。Kiniksa Pharmaceuticals, Ltd.股票所在的生物技术行业中,整体跌幅为1.59%。Kiniksa Pharmaceuticals, Ltd.公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040222035787e7da40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040222035787e7da40&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416286161","title":"Kiniksa Pharmaceuticals, Ltd.盘中异动 早盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416286161","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416286161?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:28","pubTimestamp":1709566123,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时28分,Kiniksa Pharmaceuticals, Ltd.股票出现异动,股价快速跳水5.11%。Kiniksa Pharmaceuticals, Ltd.股票所在的生物技术行业中,整体跌幅为0.06%。Kiniksa Pharmaceuticals, Ltd.公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423284387e75b34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423284387e75b34&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416906760","title":"Kiniksa Pharmaceuticals, Ltd.2023财年实现净利润14.08百万美元,同比减少92.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416906760","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416906760?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:19","pubTimestamp":1709482772,"startTime":"0","endTime":"0","summary":"12月31日,Kiniksa Pharmaceuticals, Ltd.公布财报,公告显示公司2023财年净利润为14.08百万美元,同比减少92.31%;其中营业收入为2.70亿美元,同比增加22.73%,每股基本收益为0.20美元。机构评级:截至2023年12月31日,当前有5家机构对Kiniksa Pharmaceuticals, Ltd.目标价做出预测,其中目标均价为27.40美元,其中最低目标价为24.00美元,最高目标价为32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400194087e0df1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400194087e0df1a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416757125","title":"Kiniksa Pharmaceuticals, Ltd.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416757125","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416757125?lang=zh_cn&edition=full","pubTime":"2024-03-01 01:55","pubTimestamp":1709229343,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日01时55分,Kiniksa Pharmaceuticals, Ltd.股票出现波动,股价快速拉升5.21%。Kiniksa Pharmaceuticals, Ltd.股票所在的生物技术行业中,整体跌幅为1.34%。Kiniksa Pharmaceuticals, Ltd.公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030101554487e74f1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030101554487e74f1e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415209743","title":"Kiniksa Pharmaceuticals Ltd盘中异动 早盘股价大跌5.52%报19.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415209743","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415209743?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:31","pubTimestamp":1709130692,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时31分,Kiniksa Pharmaceuticals Ltd股票出现异动,股价大幅下挫5.52%。截至发稿,该股报19.74美元/股,成交量4.3991万股,换手率0.06%,振幅10.77%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体跌幅为0.23%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822313279158bd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822313279158bd5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410057816","title":"Kiniksa Pharmaceuticals Ltd盘中异动 大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410057816","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410057816?lang=zh_cn&edition=full","pubTime":"2024-02-10 00:01","pubTimestamp":1707494474,"startTime":"0","endTime":"0","summary":"北京时间2024年02月10日00时01分,Kiniksa Pharmaceuticals Ltd股票出现波动,股价急速上涨5.10%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体涨幅为0.79%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402100001147910997d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402100001147910997d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410272403","title":"Kiniksa Pharmaceuticals Ltd盘中异动 股价大涨5.02%报19.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410272403","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410272403?lang=zh_cn&edition=full","pubTime":"2024-02-09 04:55","pubTimestamp":1707425729,"startTime":"0","endTime":"0","summary":"北京时间2024年02月09日04时55分,Kiniksa Pharmaceuticals Ltd股票出现波动,股价急速拉升5.02%。截至发稿,该股报19.03美元/股,成交量17.7327万股,换手率0.25%,振幅4.80%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体涨幅为0.37%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209045530861d4c76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240209045530861d4c76&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402407331","title":"Kiniksa Pharmaceuticals Ltd盘中异动 大幅上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402407331","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402407331?lang=zh_cn&edition=full","pubTime":"2024-01-12 03:22","pubTimestamp":1705000962,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日03时22分,Kiniksa Pharmaceuticals Ltd股票出现波动,股价大幅拉升5.12%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体跌幅为0.10%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112032243861ca0b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112032243861ca0b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2401598587","title":"Kiniksa Pharmaceuticals Ltd盘中异动 股价大跌5.05%报18.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2401598587","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2401598587?lang=zh_cn&edition=full","pubTime":"2024-01-06 01:33","pubTimestamp":1704476001,"startTime":"0","endTime":"0","summary":"北京时间2024年01月06日01时33分,Kiniksa Pharmaceuticals Ltd股票出现波动,股价快速下挫5.05%。截至发稿,该股报18.16美元/股,成交量22.0366万股,换手率0.31%,振幅5.12%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体跌幅为0.14%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010601332179068e4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010601332179068e4e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400397880","title":"Kiniksa Pharmaceuticals Ltd盘中异动 早盘快速跳水5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2400397880","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400397880?lang=zh_cn&edition=full","pubTime":"2024-01-04 22:30","pubTimestamp":1704378654,"startTime":"0","endTime":"0","summary":"北京时间2024年01月04日22时30分,Kiniksa Pharmaceuticals Ltd股票出现异动,股价快速下挫5.81%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体涨幅为0.53%。其相关个股中,Omega Therapeutics Inc、Avenue Therapeutics Inc、Kintara Therapeutics Inc涨幅较大,Kintara Therapeutics Inc、Avenue Therapeutics Inc、180 Life Sciences Corp较为活跃,换手率分别为800.74%、238.51%、190.92%,振幅较大的相关个股有Avenue Therapeutics Inc、Omega Therapeutics Inc、Phio Pharmaceuticals Corp,振幅分别为11.44%、8.06%、6.87%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240104223054861c877c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240104223054861c877c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400787545","title":"Kiniksa Pharmaceuticals Ltd盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2400787545","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400787545?lang=zh_cn&edition=full","pubTime":"2024-01-03 22:52","pubTimestamp":1704293530,"startTime":"0","endTime":"0","summary":"北京时间2024年01月03日22时52分,Kiniksa Pharmaceuticals Ltd股票出现异动,股价快速拉升5.05%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体涨幅为0.06%。其相关个股中,Neximmune Inc、Abvc Biopharma Inc、First Wave Biopharma Inc涨幅较大,Neximmune Inc、First Wave Biopharma Inc、Abvc Biopharma Inc较为活跃,换手率分别为1645.71%、645.83%、416.93%,振幅较大的相关个股有Neximmune Inc、First Wave Biopharma Inc、Abvc Biopharma Inc,振幅分别为79.16%、35.34%、25.00%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240103225210861c8382&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240103225210861c8382&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400865436","title":"Kiniksa Pharmaceuticals Ltd盘中异动 股价大涨5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2400865436","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400865436?lang=zh_cn&edition=full","pubTime":"2024-01-02 22:35","pubTimestamp":1704206134,"startTime":"0","endTime":"0","summary":"北京时间2024年01月02日22时35分,Kiniksa Pharmaceuticals Ltd股票出现异动,股价快速上涨5.99%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Longboard Pharmaceuticals Inc、Zura Bio Limited C/Wts 20/03/2028 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Soligenix Inc、Kintara Therapeutics Inc、Longboard Pharmaceuticals Inc较为活跃,换手率分别为209.48%、163.54%、37.74%,振幅较大的相关个股有Longboard Pharmaceuticals Inc、Soligenix Inc、Absci Corp,振幅分别为64.34%、26.41%、16.80%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240102223534861c7f0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240102223534861c7f0f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393711116","title":"Kiniksa Pharmaceuticals Ltd盘中异动 下午盘快速下挫5.03%报18.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393711116","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393711116?lang=zh_cn&edition=full","pubTime":"2023-12-21 02:31","pubTimestamp":1703097064,"startTime":"0","endTime":"0","summary":"北京时间2023年12月21日02时31分,Kiniksa Pharmaceuticals Ltd股票出现波动,股价快速下挫5.03%。截至发稿,该股报18.11美元/股,成交量15.7821万股,换手率0.22%,振幅4.56%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体跌幅为0.69%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122102310487e60b3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122102310487e60b3a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392990415","title":"Kiniksa Pharmaceuticals Ltd盘中异动 快速上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2392990415","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392990415?lang=zh_cn&edition=full","pubTime":"2023-12-19 01:28","pubTimestamp":1702920512,"startTime":"0","endTime":"0","summary":"北京时间2023年12月19日01时28分,Kiniksa Pharmaceuticals Ltd股票出现异动,股价大幅上涨5.56%。Kiniksa Pharmaceuticals Ltd股票所在的生物技术行业中,整体跌幅为0.45%。其相关个股中,Invivyd Inc、Panbela Therapeutics Inc、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Panbela Therapeutics Inc、Invivyd Inc、Aditxt Inc较为活跃,换手率分别为1459.12%、46.28%、38.72%,振幅较大的相关个股有Invivyd Inc、Panbela Therapeutics Inc、Celularity Inc C/Wts 16/07/2026 ,振幅分别为165.03%、146.23%、111.11%。Kiniksa Pharmaceuticals Ltd公司简介:Kiniksa Pharmaceuticals Ltd 是一家临床阶段的生物制药公司,专注于为患有衰弱性疾病的患者发现、获取、开发和商业化治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231219012832861c57d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231219012832861c57d5&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kiniksa.com","stockEarnings":[{"period":"1week","weight":0.0123},{"period":"1month","weight":0.1664},{"period":"3month","weight":-0.0085},{"period":"6month","weight":0.2584},{"period":"1year","weight":0.4966},{"period":"ytd","weight":0.1271}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kiniksa Pharmaceuticals, Ltd.于2015年7月21日在百慕大成立.该公司是一家生物制药公司,专注于发现、获取、开发和商业化治疗药物,为患有严重未满足医疗需求的使人衰弱的疾病的患者提供治疗药物。该公司的免疫调节组合ARCALYST、KPL-404和mavrilimumab基于强大的生物学原理或经过验证的机制,针对一系列未得到充分治疗的心血管和自身免疫疾病,并提供差异化的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.001355},{"month":2,"riseRate":0.666667,"avgChangeRate":0.05427},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.08579},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.018132},{"month":5,"riseRate":0.666667,"avgChangeRate":0.010336},{"month":6,"riseRate":0.833333,"avgChangeRate":0.070947},{"month":7,"riseRate":0.5,"avgChangeRate":-0.015801},{"month":8,"riseRate":0.333333,"avgChangeRate":0.024457},{"month":9,"riseRate":0.5,"avgChangeRate":-0.000526},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.120523},{"month":11,"riseRate":1,"avgChangeRate":0.236104},{"month":12,"riseRate":0.666667,"avgChangeRate":0.060395}],"exchange":"NASDAQ","name":"Kiniksa Pharmaceuticals Ltd.","nameEN":"Kiniksa Pharmaceuticals Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kiniksa Pharmaceuticals Ltd.(KNSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kiniksa Pharmaceuticals Ltd.(KNSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kiniksa Pharmaceuticals Ltd.,KNSA,Kiniksa Pharmaceuticals Ltd.股票,Kiniksa Pharmaceuticals Ltd.股票老虎,Kiniksa Pharmaceuticals Ltd.股票老虎国际,Kiniksa Pharmaceuticals Ltd.行情,Kiniksa Pharmaceuticals Ltd.股票行情,Kiniksa Pharmaceuticals Ltd.股价,Kiniksa Pharmaceuticals Ltd.股市,Kiniksa Pharmaceuticals Ltd.股票价格,Kiniksa Pharmaceuticals Ltd.股票交易,Kiniksa Pharmaceuticals Ltd.股票购买,Kiniksa Pharmaceuticals Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kiniksa Pharmaceuticals Ltd.(KNSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kiniksa Pharmaceuticals Ltd.(KNSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}